Table 4.
Evaluation of Selected (R)-N-(4-Substituted)benzyl 2-Acetamido-3-methoxypropionamide Derivatives in the Rat Hippocampal Kindled Seizure Model Assaya
![]() | ||||||
---|---|---|---|---|---|---|
Preliminary Hippocampal Kindling Test (Rat) |
Hippocampal Kindled Rat (0.25 h) (ip) |
|||||
Seizure Score |
After discharge duration (sec) |
|||||
No. | R4 | Pre-drug | Drug | Pre-drug | Drug | ED50 (mg/kg) (interval) |
(R)-17 | CH2OCH3 | 5 | 0 | 40 – 69 | 12 | 87 (58 – 129) |
(R)-20 | (CH2)3OCH3 | 4 – 5 | 2 | 21 – 40 | 21 | ND |
(R)-21 | CH=CH2 | 4 – 5 | 0 | 27 – 43 | 0–11 | ND |
(R)-34 | N3 | 4 | 0 | 29 – 65 | 0 | 6 (3 – 9) |
(R)-36 | Cl | 4 – 5 | 0 | 25 – 159 | 2 | ND |
(R)-38 | I | 5 | 0 | 17 – 36 | 0–4 | 12 (7.5 – 18) |
(R)-3b,c | H | 5 | 0 | 33 – 53 | 0 | 14 (9.1 – 18) |
phenytoinc | 4 – 5 | 3 | 42 – 72 | 51 | 34 (21 – 45) | |
phenobarbitalc | 20 (14 – 28) | |||||
valproatec | 210 (150 – 280) |
The compounds were tested through the auspices of the NINDS ASP.
Ref 23.
NINDS ASP internal control data.